Cytolysis following chemoembolization for hepatocellular carcinoma
- 1 February 1999
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 86 (2), 176-180
- https://doi.org/10.1046/j.1365-2168.1999.01014.x
Abstract
Background Lipiodolized chemoembolization of hepatocellular carcinoma (HCC) can induce fever and cytolysis, defined as an increase in serum levels of liver transaminases, which is frequently assumed to result from tumour necrosis. This study aimed to assess the causes of this syndrome, reviewing preoperative data, intraoperative findings, tumour necrosis and the status of non-tumorous liver. Methods A retrospective study was undertaken of 29 patients treated by neoadjuvant lipiodolized chemoembolization before surgical resection of HCC. Tumour necrosis was assessed in the resected specimen and scored in four stages: absent, 50 per cent or less, more than 50 per cent, and complete. The status of non-tumorous liver parenchyma was classified as either fibrotic or cirrhotic. Results Cytolysis occurred following chemoembolization in 16 patients and was associated with fever in 11. Postchemoembolization cytolysis with or without fever was more likely to develop in patients with minor fibrotic changes than in those with cirrhosis (14 of 21 with fibrosis versus two of four with cirrhosis, P < 0·05). In contrast, the extent of tumour necrosis did not correlate with the occurrence of symptoms. Conclusion These results suggest that fever and cytolysis following chemoembolization of HCC are an indication not of tumour necrosis but of injury to the non-tumorous liver.Keywords
This publication has 17 references indexed in Scilit:
- A Comparison of Lipiodol Chemoembolization and Conservative Treatment for Unresectable Hepatocellular CarcinomaNew England Journal of Medicine, 1995
- Transarterial embolization for hepatocellular carcinoma. Antibiotic prophylaxis and clinical meaning of postembolization feverJournal of Hepatology, 1995
- Postoperative prophylactic lipiodolization reduces the intrahepatic recurrence of hepatocellular carcinomaThe American Journal of Surgery, 1995
- Hepatic arterial resistance in cirrhosis with and without portal vein thrombosis: Relationships with portal hemodynamicsGastroenterology, 1995
- Treatment of hepatocellular carcinoma with transcatheter arterial embolization. Analysis of prognostic factorsCancer, 1994
- Comparison of hepatectomy and transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma: Necessity for prospective randomized trialHepatology, 1992
- Primary treatment of hepatocellular carcinoma by arterial chemoembolizationThe American Journal of Surgery, 1992
- Intrahepatic Recurrence After Resection of Hepatocellular Carcinoma Complicating CirrhosisAnnals of Surgery, 1991
- Significance of transcatheter chemoembolization combined with surgical resection for hepatocellular carcinomasCancer Chemotherapy and Pharmacology, 1989
- Transection of the oesophagus for bleeding oesophageal varicesBritish Journal of Surgery, 1973